نتایج جستجو برای: hpv 16

تعداد نتایج: 347783  

2017
Ting Fan Leung Anthony Pak-Yin Liu Fong Seng Lim Franck Thollot Helen May Lin Oh Bee Wah Lee Lars Rombo Ngiap Chuan Tan Roman Rouzier Stéphanie De Simoni Pemmaraju Suryakiran Marjan Hezareh Florence Thomas Nicolas Folschweiller Frank Struyf

This observer-blind study (clinicaltrials.gov NCT01462357) compared the immunogenicity and safety of two doses (2D) of the HPV-16/18 AS04-adjuvanted vaccine (2D of AS04-HPV-16/18) vs. two or three doses of the 4vHPV vaccine [2D or 3D of 4vHPV] in 1075 healthy girls aged 9–14 years. Girls were randomized (1:1:1) to receive 2D of AS04-HPV-16/18 at months (M) 0, 6 (N = 359), 2D of 4vHPV at M0, 6 (...

Journal: :Journal of acquired immune deficiency syndromes 2012
Jessica A Kahn Robert D Burk Kathleen E Squires Bill G Kapogiannis Bret Rudy Jiahong Xu René Gonin Nancy Liu Carol Worrell Craig M Wilson

BACKGROUND The objectives of this study were to describe the prevalence and risk factors for HPV infection among HIV-infected young women receiving their first quadrivalent HPV (HPV-6, -11, -16, and -18) vaccine dose. METHODS We recruited 16- to 23-year-old women from 14 sites for an HPV vaccine trial. At the first visit, they completed a questionnaire and were tested for cervicovaginal HPV D...

2014
Feng-Cai Zhu Wen Chen Yue-Mei Hu Ying Hong Juan Li Xun Zhang Yi-Ju Zhang Qin-Jing Pan Fang-Hui Zhao Jia-Xi Yu Yan-Shu Zhang Xiaoping Yang Cheng-Fu Zhang Haiwen Tang Helen Zhang Marie Lebacq Marie-Pierre David Sanjoy K Datta Frank Struyf Dan Bi Dominique Descamps

This phase II/III, double-blind, randomized trial assessed the efficacy, immunogenicity and safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in young Chinese women (ClinicalTrials.gov registration NCT00779766). Women aged 18-25 years from Jiangsu province were randomized (1:1) to receive HPV vaccine (n = 3,026) or Al(OH)3 control (n = 3,025) at months 0, 1 and 6. The prima...

Journal: :The Journal of infectious diseases 2014
Silvia Franceschi Iacopo Baussano

Scientists do not know precisely which elements of the immune system are important in preventing or resolving human papillomavirus (HPV) infections in unvaccinated women. HPV has a battery of immune-evasion mechanisms that include hiding within the host mucosal cells, lowlevel production of late (L) proteins, and inhibition of innate immunity and cellmediated response by early proteins [1]. HPV...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010
Beibei Lu Michael E Hagensee Ji-Hyun Lee Yougui Wu Heather G Stockwell Carrie M Nielson Martha Abrahamsen Mary Papenfuss Robin B Harris Anna R Giuliano

Our understanding of humoral response to human papillomavirus (HPV) infection has been mainly derived from studies in women. The role of serum antibodies in the natural history of HPV in men has yet to be investigated. Data from 285 male participants of a natural history study were used to determine the epidemiologic factors associated with HPV 16/18 seropositivity and explore the role of HPV 1...

Journal: :The Journal of general virology 2002
Agnieszka Bernat Paola Massimi Lawrence Banks

Previous studies have shown that the human papillomavirus type 16 (HPV-16) E6 protein binds to p300/CBP and abrogates its transcriptional co-activator function. However, there is little information on the biological consequences of this interaction and discrepancy as to whether the interaction is high-risk E6 specific or not. We performed a series of studies to compare the interactions of HPV-1...

Journal: :The Journal of infectious diseases 2000
M E Hagensee L A Koutsky S K Lee T Grubert J Kuypers N B Kiviat D A Galloway

A more sensitive luminescence immunoassay (LIA) for human papillomavirus type 16 (HPV-16) was developed and used to measure HPV-16 antibodies in cervical samples from 292 college-aged women who were examined at 4-month intervals. Of the 609 collected samples, IgG, IgA, and secretory piece-associated antibodies to HPV-16 were detected in 12%, 6%, and 8%, respectively, of samples tested. Cervical...

Journal: :The Journal of infectious diseases 1997
M E Hagensee N Kiviat C W Critchlow S E Hawes J Kuypers S Holte D A Galloway

Human papillomavirus (HPV) has been implicated in the pathogenesis of anal carcinoma, which is increased in homosexual men. Little is known about the serologic response to HPV in normal or immunosuppressed men; therefore, HIV-infected and -uninfected homosexual men were screened for HPV-6 and -16 capsid antibodies. HIV-infected men had increased HPV DNA detection but did not significantly diffe...

Journal: :Antiviral research 2007
Nitesh Mistry Peter Drobni Jonas Näslund Vivekananda Gupta Sunkari Håvard Jenssen Magnus Evander

Human papillomavirus (HPV) cause common warts, laryngeal papilloma and genital condylomata and is necessary for the development of cervical cancer. We have previously found that lactoferrin has antiviral activity against HPV-16 and others have demonstrated that lactoferricin, an N-terminal fragment of lactoferrin, has inhibitory activities against several viruses. Two cell lines and two virus t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید